Why Lipella Pharmaceuticals Stock Is Soaring Today


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Lipella Pharmaceuticals Inc (NASDAQ:LIPO) shares are trading higher Wednesday after the company announced top line results of its Phase 2a clinical trial of its drug candidate LP-10.

What To Know: Lipella completed the Phase 2a clinical trial evaluating the safety and efficacy of LP-10 for hemorrhagic cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.

All subjects tolerated LP-10 instillations and completed the study without report of product related serious adverse events. LP-10 pharmacokinetic analysis demonstrated short duration of systemic uptake. Responder analysis noted complete response in three subjects, partial response in seven subjects and no response in three subjects.

"The successful completion of the Phase 2a clinical trial of LP-10 is a critical milestone in Lipella's development. We're gratified with the results and look forward to our next step, which will be to communicate with the FDA on the study's results and the pathway forward to seeking regulatory approval for LP-10," said Jonathan Kaufman, CEO of Lipella.

Kaufman is set to present these results at Biotech Showcase 2023 Wednesday evening at 5 p.m. ET.

Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications.

See Also: Best Biotech Stocks Right Now

LIPO Price Action: Lipella shares are up 65.4% at $5.15 at time of publication, according to Benzinga Pro.

Photo: Konstantin Kolosov from Pixabay.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechPenny StocksMoversGeneralJonathan Kaufmanwhy it's moving